The pharmaceutical sector is seeing a major shift in diabetes care with the emergence of GLP-1 transdermal devices. These revolutionary delivery systems offer a potentially simple alternative to needle injections for https://katrinamruo575167.blogerus.com/62935857/glp-1-patches-a-novel-approach-to-diabetes-control